242 related articles for article (PubMed ID: 26792828)
1. 60 YEARS OF POMC: Transcriptional and epigenetic regulation of POMC gene expression.
Drouin J
J Mol Endocrinol; 2016 May; 56(4):T99-T112. PubMed ID: 26792828
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin-releasing hormone or dexamethasone regulates rat proopiomelanocortin transcription through Tpit/Pitx-responsive element in its promoter.
Murakami I; Takeuchi S; Kudo T; Sutou S; Takahashi S
J Endocrinol; 2007 May; 193(2):279-90. PubMed ID: 17470519
[TBL] [Abstract][Full Text] [Related]
3. A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins.
Lamolet B; Pulichino AM; Lamonerie T; Gauthier Y; Brue T; Enjalbert A; Drouin J
Cell; 2001 Mar; 104(6):849-59. PubMed ID: 11290323
[TBL] [Abstract][Full Text] [Related]
4. A pituitary-specific enhancer of the POMC gene with preferential activity in corticotrope cells.
Langlais D; Couture C; Sylvain-Drolet G; Drouin J
Mol Endocrinol; 2011 Feb; 25(2):348-59. PubMed ID: 21193556
[TBL] [Abstract][Full Text] [Related]
5. The T-box factor Tpit recruits SRC/p160 co-activators and mediates hormone action.
Maira M; Couture C; Le Martelot G; Pulichino AM; Bilodeau S; Drouin J
J Biol Chem; 2003 Nov; 278(47):46523-32. PubMed ID: 12970370
[TBL] [Abstract][Full Text] [Related]
6. The Ets factor Etv1 interacts with Tpit protein for pituitary pro-opiomelanocortin (POMC) gene transcription.
Budry L; Couture C; Balsalobre A; Drouin J
J Biol Chem; 2011 Jul; 286(28):25387-96. PubMed ID: 21622576
[TBL] [Abstract][Full Text] [Related]
7. The corticotroph cells from early development to tumorigenesis.
Drouin J
J Neuroendocrinol; 2022 Aug; 34(8):e13147. PubMed ID: 35524583
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific regulation of pituitary proopiomelanocortin gene transcription by corticotropin-releasing hormone, 3',5'-cyclic adenosine monophosphate, and glucocorticoids.
Gagner JP; Drouin J
Mol Endocrinol; 1987 Oct; 1(10):677-82. PubMed ID: 2856398
[TBL] [Abstract][Full Text] [Related]
9. Complex transcriptional regulation by glucocorticoids and corticotropin-releasing hormone of proopiomelanocortin gene expression in rat pituitary cultures.
Eberwine JH; Jonassen JA; Evinger MJ; Roberts JL
DNA; 1987 Oct; 6(5):483-92. PubMed ID: 3500023
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of proopiomelanocortin and pituitary-restricted transcription factor (TPIT), a new marker of normal and adenomatous human corticotrophs.
Vallette-Kasic S; Figarella-Branger D; Grino M; Pulichino AM; Dufour H; Grisoli F; Enjalbert A; Drouin J; Brue T
J Clin Endocrinol Metab; 2003 Jul; 88(7):3050-6. PubMed ID: 12843142
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenic protein (Smad)-mediated repression of proopiomelanocortin transcription by interference with Pitx/Tpit activity.
Nudi M; Ouimette JF; Drouin J
Mol Endocrinol; 2005 May; 19(5):1329-42. PubMed ID: 15695370
[TBL] [Abstract][Full Text] [Related]
12. Opposite effects of serum- and glucocorticoid-regulated kinase-1 and glucocorticoids on POMC transcription and ACTH release.
Reiter MH; Vila G; Knosp E; Baumgartner-Parzer SM; Wagner L; Stalla GK; Luger A
Am J Physiol Endocrinol Metab; 2011 Aug; 301(2):E336-41. PubMed ID: 21586695
[TBL] [Abstract][Full Text] [Related]
13. Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing.
Bousquet C; Zatelli MC; Melmed S
J Clin Invest; 2000 Dec; 106(11):1417-25. PubMed ID: 11104795
[TBL] [Abstract][Full Text] [Related]
14. Tpit determines alternate fates during pituitary cell differentiation.
Pulichino AM; Vallette-Kasic S; Tsai JP; Couture C; Gauthier Y; Drouin J
Genes Dev; 2003 Mar; 17(6):738-47. PubMed ID: 12651892
[TBL] [Abstract][Full Text] [Related]
15. Purinergic receptor ligands stimulate pro-opiomelanocortin gene expression in AtT-20 pituitary corticotroph cells.
Zhao LF; Iwasaki Y; Oki Y; Tsugita M; Taguchi T; Nishiyama M; Takao T; Kambayashi M; Hashimoto K
J Neuroendocrinol; 2006 Apr; 18(4):273-8. PubMed ID: 16503922
[TBL] [Abstract][Full Text] [Related]
16. Pro-opiomelanocortin gene: a model for negative regulation of transcription by glucocorticoids.
Drouin J; Charron J; Gagner JP; Jeannotte L; Nemer M; Plante RK; Wrange O
J Cell Biochem; 1987 Dec; 35(4):293-304. PubMed ID: 3326882
[TBL] [Abstract][Full Text] [Related]
17. Ablation of pituitary pro-opiomelanocortin (POMC) cells produces alterations in hypothalamic POMC mRNA levels and midbrain mu opioid receptor binding in a conditional transgenic mouse model.
Zhou Y; Unterwald EM; Ho A; LaForge KS; Yuferov VP; Kreuter J; Sirianni MJ; Allen RG; Kreek MJ
J Neuroendocrinol; 2001 Sep; 13(9):808-17. PubMed ID: 11578531
[TBL] [Abstract][Full Text] [Related]
18. Developmental regulation of proopiomelanocortin gene expression in the fetal and neonatal rat pituitary.
Scott RE; Pintar JE
Mol Endocrinol; 1993 Apr; 7(4):585-96. PubMed ID: 8502239
[TBL] [Abstract][Full Text] [Related]
19. Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways.
Kovalovsky D; Refojo D; Liberman AC; Hochbaum D; Pereda MP; Coso OA; Stalla GK; Holsboer F; Arzt E
Mol Endocrinol; 2002 Jul; 16(7):1638-51. PubMed ID: 12089357
[TBL] [Abstract][Full Text] [Related]
20. Of old and new diseases: genetics of pituitary ACTH excess (Cushing) and deficiency.
Drouin J; Bilodeau S; Vallette S
Clin Genet; 2007 Sep; 72(3):175-82. PubMed ID: 17718852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
